Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Rank in Stocks #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinsonโ€™s disease, Alzheimerโ€™s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Share Price
$0.2301
Last synced: 2026-08-12
Market Cap
$228.81K
Change (1 day)
-17.82%
Change (1 year)
95,775.00%
Country
US
Trade The Greater Cannabis Company, Inc. (GCAN)

Category

Stock price history for The Greater Cannabis Company, Inc. (GCAN)
Highest end of day price: $0.31 on 2026-08-01

Lowest end of day price: $0.21 on 2018-09-01
Stock price history of The Greater Cannabis Company, Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 105.21%
2025 16,126.48%
2024 -47.34%
2023 41.11%
2022 -82.95%
2021 14.35%
2020 -91.59%
2019 -74.42%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$58.34 59.83%
US
$50.11 76.63%
SE
$186.82 44.08%
FR
$62.63 5.00%
IT
$111.21 54.46%
US